Profit

Bullish On Jubilant Life Sciences: IndiaNivesh Securities

PUBLISHED ON: May 26, 2016 | Duration: 15 min, 07 sec

  
loading..
Daljeet Kohli, head- research at IndiaNivesh Securities, says Jubilant Life Sciences' fourth quarter margins of its pharma and chemicals businesses were in line with expectations. The stock looks attractive at current levels and is expected to go up to Rs 495, he adds.
ALSO WATCH
तीन महीने बाद जहांगीरपुरी में खुले बाजार

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com